NewYou can listen to Fox News articles now!
A new study shows that diacetamide lactonic acid, also known as acid, can Relieve anxiety.
This marks the first trial to evaluate the safety and efficacy of MM120 (drug formula) LSDMindMed, chief medical officer of New York biopharmaceutical company Mindmed, serves as a single treatment for patients with moderate to severe systemic anxiety.
The study was published in the Journal of the American Medical Association.
Research shows that the key to longer lifespans may be related to surprising substances.
Nearly 200 adults between the ages of 18 and 74 According to the press release, either receive a single oral dose of LSD on various DIDs or receive a placebo “virtual drug” within three months.
Dosage sessions were performed individually in a private room and were observed with two trained monitors for at least 12 hours. No psychotherapy is provided.
A new study shows that diacetamide lactonic acid, also known as acid, can relieve anxiety. (iStock)
Researchers track changes in participants Anxiety score Weeks 1, 2, 4, 8 and 12, week 4 serves as the key points of the assessment.
Four weeks later, the anxiety scores of patients receiving the highest dose were significantly lower than those of other patients.
At 12 weeks, 65% of patients taking 100 mg showed benefits, and anxiety disorders were relieved by nearly 50%.
Trump administration explores psychedelic drugs as potential mental health treatment
The researchers also tested the effects of LSD on depression and found that the highest dose was associated with significant improvement.
Carlin shared that the impact of LSD was almost instant. Psychedelic side effects include hallucinations, nausea and headaches.
LSD has been shown to reduce symptoms in adults with general anxiety disorders, with 100 microgram doses being proven most effective in clinical trials. (iStock)
Effect-dependent dose, of which 100 mg is the optimal dose. this The 200 mg dose is also significantly better than the placebo. The 25 mg and 50 mg doses showed no significant benefits.
According to Karlin, one possible study complication is “functional unblocking” in which participants in the trial could correctly guess whether they had received an active drug instead of a placebo.
Researchers found that single dose of “magic mushrooms” provides 5 years of relief from depression
Pharmaceuticals plan to conduct two large-scale Post-stage trial Track patients for longer periods of time.
If the study is considered successful, MindMed will submit drug approval to the U.S. Food and Drug Administration.
Risk and legality
LSD is classified as Plan my medicineAccording to the drug enforcement agency, this means it is considered to have the potential for abuse and has no recognized medical use.
Drugs under Schedule I shall not be legally permitted to be prescribed, distributed or used in medical care unless approved research.
If the study is considered successful, MindMed will submit experimental drugs to the FDA for approval. (iStock)
The FDA has designated LSD, psilocybin and MDMA as “Potential” Breakthrough Therapy“Dr. Marc Siegel, senior medical analyst at Fox News, told Fox News Numbers.
Miley Cyrus reveals “powerful” therapy that helps her conquer the stage horror
“The key is careful supervision and meticulous research that can monitor side effects and effectiveness,” Siegel said.
Click here to get the Fox News app
Siegel confirmed that LSD may cause hallucination, although the new study showed “very positive outcomes in about 200 patients.”
Other recorded side effects may include paranoia, mood swings, Increased heart rate and long-term psychosis, according to multiple sources.
“The key is careful supervision and meticulous research that can monitor side effects and effectiveness.”
“The return of LSD is not only cultural or scientific, but also regulatory,” Hadas Alterman, a psychedelic medicine attorney in Washington, D.C., told Fox News Digital.
The expert said that psychedelics were “placed” due to “the FDA authority expanded considerably under the 1962 Kefauver-Harris Amendment.”
Click here to sign up for our health newsletter
The legislation, also known as a drug efficacy revision, requires drug manufacturers to pass Well-controlled clinical trials Before approval.
“LSD and other psychedelic drugs have long demonstrated clinical commitment, but the excess entertainment uses of the 1960s prevented researchers from continuing to study it,” Siegel added.
“LSD and other psychedelic drugs have long demonstrated clinical commitment, but the excess entertainment uses of the 1960s kept researchers from studying it anymore,” said one doctor. (iStock)
Secretary of Health and Human Services Robert F. Kennedy Jr.
For more health articles, please visit www.foxnews.com/health
“If it is Clinical environmentWe are working to make sure that this happens within 12 months. ” RFK recently told MPs.
Psychedelic drug advocate Alterman noted that while supporting “not replacing science,” it encourages institutions like the FDA to “take this seriously”.
